Background
The Institute of Medicine (2006) recommended that cancer survivors completing primary treatment receive a survivorship care plan (SCP) based on face validity. The state of scientific knowledge regarding SCP is unclear. We conducted an integrative review of existing evidence regarding SCP.
Methods
We searched MEDLINE /PubMed, EMBASE, and CINAHL for relevant studies published between 2006 – 2013 using a combination of keywords: ‘survivors,’ ‘survivorship,’ ‘care plans,’ ‘care planning,’ ‘treatment summaries’ and ‘cancer.’ Articles were included if they (1) reported results of an empirical study; (2) included cancer survivors diagnosed at age 18 or older; (3) related to SCP; and (4) were published in English. A total of 781 records were retrieved; 77 were duplicates, 665 were abstracts or presentations, did not relate to SCP for adults or were not empirical – leaving 42 for inclusion in this review.
Results
Studies regarding SCP fell into three categories: (a) content (n=14); (b) dissemination and implementation (n=14); and (c) survivor and provider outcomes (n=14). SCP were endorsed and associated with improved knowledge, but SCP use remains sporadic. Only 4 studies were randomized controlled trials (RCT) that avoided many biases associated with observational studies. Other limitations included cross-sectional or pre-post designs, limited generalizability due to lacking sample diversity, and lack of systematic testing of data collection tools.
Conclusions
The quantity and quality of SCP research is limited. SCP were endorsed, but evidence of improved outcomes associated with SCP is limited. Future research that addresses extant studies’ methodological concerns is needed regarding SCP use, content, and outcomes.